Gonzalo Lopez - Concepedia

Author

Gonzalo Lopez

The Ohio State University ORCID

Also Known As

G. lopez, Gonzalo Lopez, Lopez G, Lopez, Gonzalo

Publications

898

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Sheba Medical Center The University of Texas MD Anderson Cancer Center The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Cancer Genetics (United States)

About

Gonzalo Lopez is an author at The Ohio State University specializing in tumor biology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	133
2	Cell Biology	3	3	117
3	Pathology	2	2	62
4	Health Sciences	1	1	32
5	Molecular Genetics	1	1	32

Gonzalo Lopez

Publications

891

Citations

H-Index

Page 1

	Year	Citations
Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression Lucia Casadei, Federica Calore, Chad J. Creighton, Cancer Research	2017	195
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma Kate Lynn J. Bill, Jeannine Garnett, Isabelle Meaux, Clinical Cancer Research	2015	106
Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma Gonzalo Lopez, Juehui Liu, Wenhong Ren, Clinical Cancer Research	2009	78
TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma <i>In vivo</i> Suizhao Wang, Wenhong Ren, Jeffery Liu, Clinical Cancer Research	2010	58
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST) Gonzalo Lopez, Kate Lynn J. Bill, Hemant K. Bid, PLoS ONE	2015	57
Cross‐flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles Lucia Casadei, Adarsh Choudhury, Patricia Sarchet, Journal of Extracellular Vesicles	2021	47
Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors Markus P. Ghadimi, Gonzalo Lopez, Keila E. Torres, Molecular Cancer Therapeutics Surgical OncologyTumor InnervationPi3k/mtor AxisPathologyMpnst Growth	2012	46
Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors Markus P. Ghadimi, Eric D. Young, Roman Belousov, Clinical Cancer Research	2012	46
Autophagy blockade enhances HDAC inhibitors’ pro-apoptotic effects Gonzalo Lopez, Keila E. Torres, Dina Lev Autophagy Chemoprevention StrategyApoptosisCell DeathPharmacotherapyAutophagy Develops	2011	39
<i>MDM2</i> Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes Lucia Casadei, Federica Calore, Danielle Braggio, Cancer Research	2019	37

Page 1